abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

85 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q3 2025.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.11M shares of 28.9M outstanding shares and own 31.57% of the company stock.
Largest 10 shareholders include Saba Capital Management, L.P. (2.59M shares), MORGAN STANLEY (871K shares), Penserra Capital Management LLC (794K shares), RAYMOND JAMES FINANCIAL INC (423K shares), NEEDHAM INVESTMENT MANAGEMENT LLC (403K shares), LPL Financial LLC (374K shares), FLAGSHIP HARBOR ADVISORS, LLC (357K shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (308K shares), Karpus Management, Inc. (300K shares), and Allspring Global Investments Holdings, LLC (235K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.